Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.600
+0.100 (2.22%)
Dec 23, 2025, 3:40 PM EST
Veradigm Market Cap
Veradigm has a market cap or net worth of $764.81 million as of December 23, 2025. Its market cap has decreased by -56.63% in one year.
Market Cap
764.81M
Enterprise Value
537.66M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.60
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 764.81M, an increase of 145.28%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 764.81M | -53.74% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |
| HST Global | 131.71M |